Indeed, SPLUNC1 acts as a gene modifier in both CF and asthma (Saferali et al., 2015; Schaefer et al., 2019) and we speculate that reduced SPLUNC1 levels may aberrantly increase Orai1 levels and SOCE in both diseases, leading to increased inflammation. Here, ORAI1 is linked to cystic fibrosis.